Cervical cord compression from plexiform neurofibromas in neurofibromatosis 1.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 2095617)

Published in J Neurol Neurosurg Psychiatry on July 17, 2007


J R Leonard1, R E Ferner, N Thomas, D H Gutmann

Author Affiliations

1: Department of Neurosurgery, St Louis Children's Hospital and Washington University School of Medicine, St Louis, Missouri, USA.

Articles cited by this

Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol (1988) 8.61

Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety. Neuroradiology (1999) 1.99

Neurological complications of neurofibromatosis type 1 in adulthood. Brain (1999) 1.58

Cervical neuromas with extradural components: surgical management in a series of 57 patients. Neurosurgery (1997) 1.44

Multiple roles for neurofibromin in skeletal development and growth. Hum Mol Genet (2007) 1.29

Long-term outcome after removal of spinal neurofibroma. J Neurosurg (1995) 1.28

Management of head and neck plexiform neurofibromas in pediatric patients with neurofibromatosis type 1. Arch Otolaryngol Head Neck Surg (2005) 1.07

Neurofibromatosis of the cervical spine. A report of eight cases. J Bone Joint Surg Br (1992) 0.97

Spinal neurofibroma presenting as atlanto-axial subluxation in von Recklinghausen neurofibromatosis. Neurofibromatosis (1989) 0.94

Cervical neurofibromas in children with NF-1. Pediatr Radiol (1999) 0.94

Surgical management of spinal cord compression from plexiform neurofibromas in patients with neurofibromatosis 1. Neurosurgery (1998) 0.87

Quadriplegia in a 10 year-old boy due to multiple cervical neurofibromas. Spine (Phila Pa 1976) (2003) 0.86

Neurofibromatosis: an unusual cause of cervical myopathy. J Spinal Cord Med (1998) 0.82

[Type I neurofibromatosis presenting as a progressive cervical myelopathy. The first case reported in Kaxinawa Indians]. Rev Neurol (2000) 0.81

Newborn apnea caused by a neurofibroma at the craniocervical junction. Can J Neurol Sci (1994) 0.81

Articles by these authors

Human gene mutation database-a biomedical information and research resource. Hum Mutat (2000) 6.87

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet (2009) 6.83

Matching using estimated propensity scores: relating theory to practice. Biometrics (1996) 6.73

Newly licensed drugs. BMJ (1996) 6.68

Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science (2011) 4.72

Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature (1992) 4.42

Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13

X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet (1996) 3.90

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev (2001) 3.65

Medical errors. Medical schools can teach safe drug prescribing and administration. BMJ (2001) 3.53

Joining the DoTS: new approach to classifying adverse drug reactions. BMJ (2003) 3.47

Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ (2006) 3.02

Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet (2005) 2.56

Is there a cure for drug errors? BMJ (1995) 2.55

Interpreting hospital mortality data. The role of clinical risk adjustment. JAMA (1989) 2.53

Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am (1986) 2.49

Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients. BMJ (1995) 2.36

Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Br Med J (Clin Res Ed) (1986) 2.33

Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies. Lancet (1982) 2.30

D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28

Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol (1997) 2.28

An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23

In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Mol Biochem Parasitol (1985) 2.20

Predicting hospital-associated mortality for Medicare patients. A method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure. JAMA (1989) 2.19

Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res (2001) 2.13

Misleading drug packaging. BMJ (1995) 2.12

cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics (1991) 2.03

Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma. Neurology (2009) 2.00

Plexiform neurofibromas in NF1: toward biologic-based therapy. Neurology (2002) 1.90

'The strategy of desire' and rational prescribing. Br J Clin Pharmacol (1994) 1.84

High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas. Oncogene (2008) 1.84

Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet (2000) 1.76

A closer look at water-related geologic activity on Mars. Science (2007) 1.71

Mineralization of linear alkylbenzene sulfonate by a four-member aerobic bacterial consortium. Appl Environ Microbiol (1991) 1.68

Minocycline for acne. BMJ (1996) 1.61

Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet (2000) 1.61

Optical observations of comet Hale-Bopp (C/1995 O1) at large heliocentric distances before perihelion. Science (1997) 1.58

Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene (1997) 1.55

Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas. Neurology (2001) 1.54

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain (1999) 1.48

Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme. Br Med J (Clin Res Ed) (1987) 1.46

Microbial DNA profiling by multiplex terminal restriction fragment length polymorphism for forensic comparison of soil and the influence of sample condition. J Appl Microbiol (2008) 1.45

Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet (1993) 1.45

Why are thiazide diuretics declining in popularity? J Hum Hypertens (2001) 1.44

The dental caries experience of 5-year-old children in Great Britain (2005/6). Surveys co-ordinated by the British Association for the study of community dentistry. Community Dent Health (2007) 1.43

Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J Biol Chem (1999) 1.43

A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol (1993) 1.43

Lead poisoning from Asian traditional remedies in the West Midlands--report of a series of five cases. Hum Exp Toxicol (1995) 1.42

Alternative venlafaxine kinetics in overdose. J Clin Pharm Ther (2002) 1.40

Measurement of quality of life for elderly people on dialysis. Br J Nurs (1992) 1.38

Associations of fat distribution and obesity with hypertension in a bi-ethnic population: the ARIC study. Atherosclerosis Risk in Communities Study. Obes Res (2000) 1.35

Rain, winds and haze during the Huygens probe's descent to Titan's surface. Nature (2005) 1.34

SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype. J Med Genet (2009) 1.32

Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection. Hepatology (2001) 1.32

Accuracy of radiographer plain radiograph reporting in clinical practice: a meta-analysis. Clin Radiol (2005) 1.31

Improving prescribing using a rule based prescribing system. Qual Saf Health Care (2004) 1.29

Work site group meetings and the effectiveness of a televised smoking cessation intervention. Am J Community Psychol (1987) 1.29

Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet (1999) 1.29

The dental caries experience of 11-year-old children in Great Britain. Surveys coordinated by the British Association for the Study of Community Dentistry in 2004 / 2005. Community Dent Health (2006) 1.28

Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet (2000) 1.27

Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Qual Saf Health Care (2010) 1.27

Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs). Hum Mutat (2008) 1.25

Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther (2004) 1.23

Mammalian target of rapamycin: master regulator of cell growth in the nervous system. Histol Histopathol (2007) 1.22

Profile of diabetic foot complications and its associated complications--a multicentric study from India. J Assoc Physicians India (2005) 1.22

Merlin differentially associates with the microtubule and actin cytoskeleton. J Neurosci Res (1998) 1.21

Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol (2001) 1.21

Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br J Neurosurg (2005) 1.21

Hazards, risks and reality. Br J Clin Pharmacol (1992) 1.20

The use of flanking markers in prediction for Duchenne muscular dystrophy. Arch Dis Child (1986) 1.19

Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology (2004) 1.17

NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Am J Pathol (2001) 1.16

Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol (2000) 1.16

Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. Proc Natl Acad Sci U S A (1980) 1.16

Paget's disease of bone: experience from a centre in southern India. J Assoc Physicians India (2006) 1.14

Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. J Neuropathol Exp Neurol (2000) 1.14

Seasonal erosion and restoration of Mars' northern polar dunes. Science (2011) 1.13

Adverse drug reactions: who is to know? BMJ (1993) 1.13

An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity. Proc Natl Acad Sci U S A (1985) 1.11

Glucocorticoid-induced cell-size changes and nuclear fragility in rat thymocytes. Mol Cell Endocrinol (1981) 1.10

Outcome of varicella pneumonitis in immunocompetent adults requiring treatment in a high dependency unit. J Infect (2001) 1.10

Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Am J Med Genet (2000) 1.09

Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytoma. Neurology (2006) 1.09

Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. Br J Clin Pharmacol (2001) 1.09

The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms. Am J Pathol (2001) 1.08

The primary enzyme defect in hereditary coproporphyria. Lancet (1976) 1.08

Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers. Vaccine (2005) 1.07

Observations of comet 19P/Borrelly by the miniature integrated camera and spectrometer aboard Deep Space 1. Science (2002) 1.07

Identification of novel deletion breakpoints bordered by segmental duplications in the NF1 locus using high resolution array-CGH. J Med Genet (2005) 1.06

Genotype phenotype correlation in Wilson's disease within families--a report on four south Indian families. World J Gastroenterol (2008) 1.06

Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene (2011) 1.05

Correlates of recent suicide attempts in a triethnic group of adolescents. J Nurs Scholarsh (2001) 1.05

Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre. Br Med J (Clin Res Ed) (1983) 1.05

Sex and race differences in short-term prognosis after acute coronary heart disease events: the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J (1999) 1.04

Modification of the catalytic subunit of bovine heart cAMP-dependent protein kinase with affinity labels related to peptide substrates. J Biol Chem (1982) 1.04

Healthcare planning in north-east India: a survey on diabetes awareness, risk factors and health attitudes in a rural community. J Assoc Physicians India (2009) 1.04

Desmopressin and bleeding time in patients with cirrhosis. Br Med J (Clin Res Ed) (1985) 1.03

Comparative tolerability profiles of oral antidiabetic agents. Drug Saf (1994) 1.03

Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. Neurobiol Dis (1995) 1.02